tiprankstipranks
Trending News
More News >
Idexx Laboratories (IDXX)
:IDXX
US Market

Idexx Laboratories (IDXX) Earnings Dates, Call Summary & Reports

Compare
2,020 Followers

Earnings Data

Report Date
Aug 04, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
3.28
Last Year’s EPS
2.44
Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 01, 2025
|
% Change Since: 20.15%
|
Next Earnings Date:Aug 04, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive sentiment with strong revenue growth, successful product launches, and significant international expansion. However, there are challenges, including a decline in U.S. clinical visits and pressures from the macroeconomic and trade environment.
Company Guidance
During the IDEXX Laboratories' first quarter 2025 earnings call, CFO Andrew Emerson reported a 5% organic revenue growth, driven by a 4.5% increase in CAG Diagnostic recurring revenues and a 9% growth in both veterinary software and diagnostic imaging. Despite a 2.6% decline in U.S. clinical visits, IDEXX achieved an EPS of $2.96, reflecting a 5% increase as reported and a 7% growth on a comparable basis. The company placed 4,163 CAG premium instruments, although this represented a 13% decline from the previous year, with U.S. placements up by 12%. IDEXX sustained a strong customer base, with a 9% rise in the global premium instrument installed base, and maintained a 7% organic growth in water and 4% in livestock, poultry, and dairy revenues. The company updated its 2025 outlook to account for foreign exchange benefits and concluded litigation expenses while holding its full-year organic growth forecast at 6% to 9%.
Solid Start to 2025
IDEXX achieved a solid start to 2025 with overall revenues increasing 5% organically, supported by a 4.5% organic growth in CAG Diagnostic recurring revenues.
Strong International Growth
International CAG diagnostic recurring revenue organic growth was 8.5%, reflecting benefits from net price realization and strong volume gains.
EPS and Profit Growth
EPS delivery was $2.96 per share, delivering 5% growth as reported and 7% growth on a comparable basis.
Expansion in Premium Instrument Install Base
IDEXX achieved a 9% expansion of the premium instrument install base and placed 1,544 instruments in the U.S., an increase of 12% year-over-year.
Launch of IDEXX Cancer Dx
IDEXX launched IDEXX Cancer Dx for early detection of canine lymphoma, with over 1,000 practices ordering the test within a month of launch.
Continued Innovation with IDEXX inVue Dx
Strong pre-order momentum and successful controlled launch of IDEXX inVue Dx, with over 900 placements through the end of April, transitioning to full launch.
Strong Software Ecosystem Performance
Veterinary software and diagnostic imaging revenues increased 9%, driven by reoccurring revenues and momentum in cloud-based software placements.
Resilient Pet Population
Estimated pet population sustained in 2024 at similar levels to the prior year, representing approximately 3% CAGR versus 2019 baseline.

Idexx Laboratories (IDXX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IDXX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 04, 2025
2025 (Q2)
3.28 / -
2.44
May 01, 2025
2025 (Q1)
2.85 / 2.96
2.815.34% (+0.15)
Feb 03, 2025
2024 (Q4)
2.40 / 2.62
2.3212.93% (+0.30)
Oct 31, 2024
2024 (Q3)
2.68 / 2.80
2.5310.67% (+0.27)
Aug 06, 2024
2024 (Q2)
2.88 / 2.44
2.67-8.61% (-0.23)
May 01, 2024
2024 (Q1)
2.71 / 2.81
2.5510.20% (+0.26)
Feb 05, 2024
2023 (Q4)
2.12 / 2.32
2.0513.17% (+0.27)
Nov 01, 2023
2023 (Q3)
2.37 / 2.53
2.1517.67% (+0.38)
Aug 01, 2023
2023 (Q2)
2.47 / 2.67
1.5671.15% (+1.11)
May 02, 2023
2023 (Q1)
2.42 / 2.55
2.2712.33% (+0.28)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IDXX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 01, 2025
$432.65$471.38+8.95%
Feb 03, 2025
$422.05$469.04+11.13%
Oct 31, 2024
$451.08$406.92-9.79%
Aug 06, 2024
$455.08$469.37+3.14%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Idexx Laboratories (IDXX) report earnings?
Idexx Laboratories (IDXX) is schdueled to report earning on Aug 04, 2025, TBA Not Confirmed.
    What is Idexx Laboratories (IDXX) earnings time?
    Idexx Laboratories (IDXX) earnings time is at Aug 04, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IDXX EPS forecast?
          IDXX EPS forecast for the fiscal quarter 2025 (Q2) is 3.28.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis